Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
for
veterinarians
Order Services via Vet Portal
Request Pricing
Clinical Case Studies
Our Science & Publications
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Our Science & Publications
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science & Publications
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Scientific Publications
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma
Frontiers in Oncology
Learn More →
Presentations
AI-driven Personalized Medicine for Cancer Care
Precision Medicine World Conference 2024
Learn More →
In the News
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
TechCrunch
Learn More →
Press Releases
ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Business Wire
Learn More →
Presentations
Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Identification of drug response biomarkers for canine lymphoma in large-scale NGS screen
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Impact of AI on clinical practice and outcome
Veterinary Cancer Society Annual Conference 2023
Learn More →
Presentations
Canine Lymphoma Diagnostics Past, Present and Future: How AI technology and genetics are pushing the boundaries in veterinary medicine
Veterinary Cancer Society Annual Conference 2023
Learn More →
In the News
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
USA Today
Learn More →
Scientific Publications
Prognostic value of European LeukemiaNet 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia
Haematologica
Learn More →
In the News
Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How
Innovative Veterinary Care Journal
Learn More →
In the News
How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue
Innovative Veterinary Care Journal
Learn More →
In the News
ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys
Innovative Veterinary Care Journal
Learn More →
In the News
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times
Learn More →
Press Releases
ImpriMed Celebrates the Milestone of 4,000 Dog Blood Cancer Patients
Business Insider
Learn More →
In the News
New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships
Innovative Veterinary Care Journal
Learn More →
Scientific Publications
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma
npj Precision Oncology
Learn More →
Presentations
ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care
Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Learn More →
Previous
Next
